Results 51 to 60 of about 1,076,152 (158)

Stem Cell Transplantation for Primary Immunodeficiency Disease: Experience of a Singapore Hospital

open access: yesWorld Allergy Organization Journal, 2012
We retrospectively analyzed the outcomes of hematopoietic stem cell transplantation in 7 patients with primary immunodeficiency diseases treated at the National University Hospital, Singapore, over the period from December 1996 to January 2010.
Alison Joanne Lee, MBBS, MRCPCH, MMed   +5 more
doaj   +1 more source

Minor Clinical Impact of COVID-19 Pandemic on Patients With Primary Immunodeficiency in Israel

open access: yesFrontiers in Immunology, 2021
In the last few months the world has witnessed a global pandemic due to severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection causing coronavirus disease 2019 (COVID-19).
Nufar Marcus   +55 more
doaj   +1 more source

Newborn Screening for Severe Primary Immunodeficiency Diseases in Sweden—a 2-Year Pilot TREC and KREC Screening Study

open access: yesJournal of Clinical Immunology, 2016
Newborn screening for severe primary immunodeficiencies (PID), characterized by T and/or B cell lymphopenia, was carried out in a pilot program in the Stockholm County, Sweden, over a 2-year period, encompassing 58,834 children.
M. Barbaro   +8 more
semanticscholar   +1 more source

The New Formulations of Immunoglobulin Replacement Therapies and Future Aspects

open access: yesTurkish Journal of Immunology
Immunoglobulin replacement therapy (IgRT) stands as the established method of treatment for numerous inborn errors of immunity (IEI). Over the past six decades, there have been notable advancements in the dosing, processing, and administration routes of ...
Elif Karakoç-aydıner
doaj   +1 more source

Recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin infusion in primary immunodeficiency diseases.

open access: yesImmunotherapy, 2017
Most primary immunodeficiency diseases (PIDDs) resulting in antibody deficiency require intravenous or subcutaneous immunoglobulin G (SCIG) replacement therapy.
R. Wasserman
semanticscholar   +1 more source

Allergic Manifestation in Paediatric Patients with Primary Immunodeficiency Diseases

open access: yesJournal of Medical Science, 2020
Introduction. Primary immunodeficiency diseases (PID) are a diverse group of rare genetic disorders that affect the development and/or function of the immune system.
Joanna Pawłowska   +4 more
doaj   +1 more source

Primary Immunodeficiency Diseases in Highly Consanguineous Populations from Middle East and North Africa: Epidemiology, Diagnosis, and Care

open access: yesFrontiers in Immunology, 2017
Middle East and North Africa region (MENA)1 populations are of different ethnic origins. Consanguineous marriages are common practice with an overall incidence ranging between 20 and 50%.
H. Al-Mousa, B. Al-Saud
semanticscholar   +1 more source

Autoantibodies directed against insulin receptor during the course of Castleman disease: a new case reaffirming autoimmune hypoglycemia as a relapse warning signal

open access: yesEuropean Journal of Case Reports in Internal Medicine
This case study presents the case of a 54-year-old human immunodeficiency virus (HIV)-positive male who developed type B insulin resistance syndrome (TBIRS) in conjunction with a relapse of human herpesvirus 8 (HHV8)-positive multicentric Castleman ...
Xavier Jannot   +6 more
doaj   +1 more source

A Review of Primary Immunodeficiency Diseases with Skin Manifestations

open access: yesMajallah-i Dānishgāh-i ’Ulūm-i Pizishkī-i Shahīd Ṣadūqī Yazd, 2022
Introduction: Primary immunodeficiencies (PID) are rare heterogeneous disorders with defects in which one or more components of the immune system are malfunctioning.
Abbas Khalili
doaj  

Home - About - Disclaimer - Privacy